Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Capstone Therapeutics Corp. (CAPS) had Debt to Equity Ratio of 0.60 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.90M |
|
$-2.43M |
|
$6.57M |
|
$1.32M |
|
$9.33M |
|
$-1.43M |
|
$-0.30M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.43M |
|
$-1.31M |
|
5.19M |
|
5.19M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$16.71M |
|
$1.53M |
|
$35.50M |
|
$52.21M |
|
$14.66M |
|
$7.54M |
|
$10.58M |
|
$25.24M |
|
$26.97M |
|
$3.62M |
|
$26.97M |
|
5.19M |
|
| Cash Flow Statement Financials | |
$-2.29M |
|
-- |
|
$4.02M |
|
$0.01M |
|
$1.74M |
|
$1.73M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.14 |
|
-- |
|
-- |
|
0.22 |
|
|
Debt to Equity Ratio |
0.60 |
16.77% |
|
-18.08% |
|
-18.08% |
|
-- |
|
-21.88% |
|
-30.80% |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.67 |
|
1.75 |
|
51.48 |
|
-6.41% |
|
-47.70% |
|
-3.31% |
|
-5.01% |
|
$5.20 |
|
$-0.44 |
|
$-0.44 |
|